312 related articles for article (PubMed ID: 2172383)
21. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
Ferreri NR; Howland WC; Spiegelberg HL
J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
[TBL] [Abstract][Full Text] [Related]
22. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen.
Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J
J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes.
Dugas B; Renauld JC; Pène J; Bonnefoy JY; Peti-Frère C; Braquet P; Bousquet J; Van Snick J; Mencia-Huerta JM
Eur J Immunol; 1993 Jul; 23(7):1687-92. PubMed ID: 7686859
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes.
Wu CY; Sarfati M; Heusser C; Fournier S; Rubio-Trujillo M; Peleman R; Delespesse G
J Clin Invest; 1991 Mar; 87(3):870-7. PubMed ID: 1825666
[TBL] [Abstract][Full Text] [Related]
25. A novel pathway of human B cell activation initiated by CK226 surface antigen.
Poggi A; Maggi E; Biagiotti R; Giudizi MG; Almerigogna F; Pella N; Caligaris-Cappio F; Romagnani S; Moretta L
Eur J Immunol; 1990 May; 20(5):1161-5. PubMed ID: 2141569
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
27. Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes.
Pfeil T; Fischer A; Bujanowski-Weber J; Luther H; Altmeyer P; König W
Immunology; 1989 Sep; 68(1):37-44. PubMed ID: 2530155
[TBL] [Abstract][Full Text] [Related]
28. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
[TBL] [Abstract][Full Text] [Related]
29. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
30. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
[TBL] [Abstract][Full Text] [Related]
31. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.
Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W
Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859
[TBL] [Abstract][Full Text] [Related]
32. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
33. Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils.
Kawabe T; Maeda Y; Maekawa N; Tanaka M; Mayumi M; Mikawa H; Yodoi J
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():989-95. PubMed ID: 1825444
[TBL] [Abstract][Full Text] [Related]
34. CD20 monoclonal antibodies decrease interleukin-4-stimulated expression of the low-affinity receptor for IgE (Fc epsilon RII/CD23) in human B cells by increasing the extent of its cleavage.
Bourget I; Di Berardino W; Breittmayer JP; Grenier-Brossette N; Plana-Prades M; Bonnefoy JY; Cousin JL
Eur J Immunol; 1995 Jul; 25(7):1872-6. PubMed ID: 7542593
[TBL] [Abstract][Full Text] [Related]
35. Formation and effects of leukotriene B4 in human lymphocytes.
Odlander B; Jakobsson PJ; Medina JF; Rådmark O; Yamaoka KA; Rosén A; Claesson HE
Int J Tissue React; 1989; 11(6):277-89. PubMed ID: 2561484
[TBL] [Abstract][Full Text] [Related]
36. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
37. Expression of B cell surface receptors. II. IL-4 can accelerate the developmental expression of the murine B cell IgE Fc receptor.
Waldschmidt TJ; Conrad DH; Lynch RG
J Immunol; 1989 Nov; 143(9):2820-7. PubMed ID: 2530279
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
39. Functional interaction between B cell subpopulations defined by CD23 expression.
Armitage RJ; Goff LK
Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
[TBL] [Abstract][Full Text] [Related]
40. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]